Darling Therapeutics is a discovery stage pharmaceutical company focused on addressing ultra-rare metabolic disorders via a platform approach.
Working at the cutting edge of medicine, we have an IRS EIN (88-2546870) and are a registered company with the name Darling Therapeutics LLC in San Francisco, California, USA and the name Darling Therapeutics Ltd in London, England, UK. Darling Therapeutics LLC is converting into Darling Therapeutics Inc in California to ease fundraising in line with federal and state securities regulations for private placement, unregistered securities.
Forward looking statements cannot be guaranteed. Projected revenues cannot be guaranteed. Pharmaceuticals is a highly regulated industry.